Results 21 to 30 of about 19,553 (185)

Domain swapping of complementarity-determining region in nanobodies produced by Pichia pastoris

open access: yesAMB Express, 2019
Easy preparation of chimeric nanobodies with various scaffolds is important for customizing abilities of nanobodies toward practical utilization. To accomplish high-throughput production of various nanobodies, utilization of microbes is an attractive ...
Natsuko Miura   +7 more
doaj   +1 more source

Facile isolation of high-affinity nanobodies from synthetic libraries using CDR-swapping mutagenesis

open access: yesSTAR Protocols, 2022
Summary: The generation of high-affinity nanobodies for diverse biomedical applications typically requires immunization or affinity maturation. Here, we report a simple protocol using complementarity-determining region (CDR)-swapping mutagenesis to ...
Jennifer M. Zupancic   +2 more
doaj   +1 more source

Identification and characterization of nanobodies targeting the EphA4 receptor [PDF]

open access: yes, 2017
The ephrin receptor A4 (EphA4) is one of the receptors in the ephrin system that plays a pivotal role in a variety of cell-cell interactions, mostly studied during development. In addition, EphA4 has been found to play a role in cancer biology as well as
Chavez-Gutierrez, Lucia   +16 more
core   +2 more sources

Recent advances of nanobody applications in diagnosis and detection

open access: yesMedComm – Biomaterials and Applications, 2023
Nanobodies (Nbs) are the variable domain of heavy‐chain antibodies derived from the blood of camelids or sharks. Nanobodies are the smallest antibody fragment with intact antigen‐binding ability.
Qianling Su   +5 more
doaj   +1 more source

Chemogenetic Control of Nanobodies [PDF]

open access: yesNature Methods, 2019
ABSTRACTWe introduce an engineered nanobody whose affinity to green fluorescent protein (GFP) can be switched on and off with small molecules. By controlling the cellular localization of GFP fusion proteins, the engineered nanobody allows to study their role in basic biological processes, an approach that should be applicable to numerous previously ...
Farrants, Helen   +9 more
openaire   +3 more sources

Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design

open access: yesScientific Reports, 2021
Enterotoxigenic Escherichia coli (ETEC) is estimated to cause approximately 380,000 deaths annually during sporadic or epidemic outbreaks worldwide.
Alla Amcheslavsky   +18 more
doaj   +1 more source

Nanobodies as tools to understand, diagnose, and treat African trypanosomiasis [PDF]

open access: yes, 2017
African trypanosomes are strictly extracellular protozoan parasites that cause diseases in humans and livestock and significantly affect the economic development of sub-Saharan Africa.
Caljon, Guy   +5 more
core   +1 more source

NANOBODIES: STRUCTURE, MANUFACTURING, APPLICATION (REVIEW)

open access: yesРазработка и регистрация лекарственных средств, 2019
Introduction. Single-domain antibodies (nanobodies) are composed of the heavy-chain variable domain only. Compared to conventional immunoglobulins G (IgG) nanobodies have such qualities as: high bioavailability, ability to bind epitopes that are ...
A. V. Shatalova   +3 more
doaj   +1 more source

A general approach for stabilizing nanobodies for intracellular expression

open access: yeseLife, 2022
Conventional antibodies and their derived fragments are difficult to deploy against intracellular targets in live cells, due to their bulk and structural complexity.
John G Dingus   +4 more
doaj   +1 more source

Oligoclonal selection of nanobodies targeting vascular endothelial growth factor

open access: yesJournal of Immunotoxicology, 2019
While monoclonal antibodies are efficient therapeutics for cancer treatment, nanobodies or variable heavy domain – due to their small size, high stability, and solubility – have many advantages in comparison.
Mehrdad Ahadi   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy